High Tech Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,982	13,076	7,759	3,483	7,880	11,275
Short-Term Investments	300	270	-	-	-	-
Trading Asset Securities	191.64	1,084	-	1,882	-	1,363
Cash & Short-Term Investments	8,474	14,430	7,759	5,365	7,880	12,637
Cash Growth	-45.61%	85.97%	44.63%	-31.92%	-37.64%	1117.51%
Accounts Receivable	15,866	11,319	20,330	24,443	28,476	9,413
Other Receivables	55.91	34.54	27.43	40.1	78.47	58.39
Receivables	15,922	11,354	20,357	24,483	28,555	9,472
Inventory	48,050	43,727	34,813	25,498	14,676	17,708
Prepaid Expenses	1,525	1,476	1,304	1,191	885.83	545.12
Other Current Assets	48.99	4.19	1.13	33.78	43.53	126.73
Total Current Assets	74,020	70,991	64,234	56,571	52,040	40,488
Property, Plant & Equipment	67,752	68,854	72,002	75,001	74,934	80,544
Long-Term Investments	2,271	2,451	3,061	2,076	2,198	1,768
Long-Term Deferred Tax Assets	795.26	685.68	505.05	508.51	1,920	-
Other Long-Term Assets	513.7	714.06	287.6	901.23	1,110	136.16
Total Assets	145,352	143,697	140,090	135,058	132,202	122,937
Accounts Payable	8,191	6,628	5,348	8,692	13,130	10,451
Accrued Expenses	865.77	769.29	1,177	1,203	633.1	608.08
Short-Term Debt	-	-	7,940	11,447	10,000	10,000
Current Portion of Long-Term Debt	-	-	-	-	6,337	-
Current Portion of Leases	18.26	21.6	28.37	26.85	23.71	2.2
Current Income Taxes Payable	286.57	1,626	3,293	174.79	214.38	-
Current Unearned Revenue	-	-	-	-	178.69	570
Other Current Liabilities	6,664	3,474	1,160	1,241	1,222	1,072
Total Current Liabilities	16,026	12,519	18,946	22,785	31,738	22,703
Long-Term Debt	-	-	-	5,000	-	5,928
Long-Term Leases	8.87	12.01	33.61	25.78	63.55	47.89
Pension & Post-Retirement Benefits	-	-	-	-	-	147.96
Other Long-Term Liabilities	508.06	493.78	1,372	252.56	461.27	225.66
Total Liabilities	16,542	13,025	20,352	28,064	32,263	29,052
Common Stock	5,317	5,317	5,317	3,544	3,544	3,544
Additional Paid-In Capital	23,290	23,290	23,290	25,068	25,068	25,068
Retained Earnings	100,209	102,071	91,138	78,382	71,327	65,273
Treasury Stock	-5.35	-5.35	-5.35	-	-	-
Comprehensive Income & Other	0	0	0	0	0	0
Shareholders' Equity	128,810	130,671	119,738	106,994	99,939	93,885
Total Liabilities & Equity	145,352	143,697	140,090	135,058	132,202	122,937
Total Debt	27.13	33.61	8,002	16,500	16,424	15,978
Net Cash (Debt)	8,447	14,396	-243.03	-11,135	-8,543	-3,340
Net Cash Growth	11.23%	-	-	-	-	-
Net Cash Per Share	789.38	1345.34	-22.86	-1570.78	-803.46	-314.15
Filing Date Shares Outstanding	10.63	10.63	10.63	7.09	10.63	10.63
Total Common Shares Outstanding	10.63	10.63	10.63	7.09	10.63	10.63
Working Capital	57,994	58,472	45,288	33,786	20,302	17,786
Book Value Per Share	12114.59	12289.70	11261.43	15093.47	9398.78	8829.44
Tangible Book Value	128,810	130,671	119,738	106,994	99,939	93,885
Tangible Book Value Per Share	12114.59	12289.70	11261.43	15093.47	9398.78	8829.44
Land	8,036	8,036	7,933	7,933	7,880	7,832
Buildings	58,443	58,440	57,923	53,974	52,056	52,671
Machinery	49,555	45,483	45,082	47,960	43,826	43,765
Construction In Progress	74.5	335.5	96	2,326	554	408.55